- Palisade Bio press release (NASDAQ:PALI): FY GAAP EPS of -$1.80 misses by $0.85.
- Revenue of $0.25M.
- As of December 31, 2023, the Company had cash, cash equivalents and restricted cash of $12.5 million. The Company believes it has sufficient cash to fund its currently planned operations into the first quarter of 2025.
Palisade Bio GAAP EPS of -$1.80 misses by $0.85, revenue of $0.25M
Recommended For You
More Trending News
About PALI Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PALI | - | - |
| Palisade Bio, Inc. | ||